TradingKey

关于 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. 致力于为生命科学研究和临床诊断市场开发、制造和营销一系列产品。该公司提供一系列产品和系统，用于分离复杂的化学和生物材料并识别、分析和纯化其成分。该公司通过两个部门运营：生命科学和临床诊断。生命科学部门开发、制造和营销用于生物研究、生物制药生产过程、食品检测制度和科学教育的仪器、系统、试剂和消耗品。其临床诊断部门设计、制造、营销和支持测试系统、信息系统、测试套件和专门的质量控制，为全球诊断市场的临床实验室提供服务。这些产品销往医院实验室、诊断参考实验室、输血实验室和医生办公室实验室。

公司简介

公司代码BIO

公司名称Bio Rad Laboratories Inc

上市日期Mar 17, 1980

成立日期1975

CEOMr. Norman D. Schwartz

员工数量7700

证券类型Ordinary Share

年结日Mar 17

公司地址1000 Alfred Nobel Dr

城市HERCULES

上市交易所NYSE Consolidated

国家United States of America

邮编94547

电话15107247000

网址https://www.bio-rad.com/

公司代码BIO

上市日期Mar 17, 1980

成立日期1975

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Norman D. Schwartz

Chairman of the Board, Chief Executive Officer

442.79K

+0.49%

Ms. Colleen Corey

Executive Vice President, Global Human Resources

18.48K

+7.29%

Mr. Michael Crowley

Executive Vice President - Global Commercial Operations

8.17K

--

Mr. Gregory K. (Greg) Hinckley, CPA

Lead Independent Director

808.00

+61.60%

Mr. Sedat Evran

Executive Vice President - Global Supply Chain

729.00

+3545.00%

Mr. Arnold A. Pinkston

Independent Director

308.00

--

Mr. Jeffrey L. (Jeff) Edwards

Independent Director

308.00

--

Ms. Eva Anette Engelhardt

Executive Vice President, President of Clinical Diagnostics Group

157.00

--

Ms. Courtney C Enloe

Executive Vice President, General Counsel, Secretary

119.00

--

Ms. Melinda Litherland

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Norman D. Schwartz

Chairman of the Board, Chief Executive Officer

442.79K

+0.49%

Ms. Colleen Corey

Executive Vice President, Global Human Resources

18.48K

+7.29%

Mr. Michael Crowley

Executive Vice President - Global Commercial Operations

8.17K

--

Mr. Gregory K. (Greg) Hinckley, CPA

Lead Independent Director

808.00

+61.60%

Mr. Sedat Evran

Executive Vice President - Global Supply Chain

729.00

+3545.00%

Mr. Arnold A. Pinkston

Independent Director

308.00

--

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

United States

241.70M

41.29%

Europe

199.80M

34.13%

APAC

104.10M

17.78%

Other

39.80M

6.80%

业务

地区

暂无数据

股东统计

更新时间: 5月16日周五

持股股东

股东类型

持股股东

占比

First Eagle Investment Management, L.L.C.

10.36%

The Vanguard Group, Inc.

8.59%

Alice N. Schwartz Revocable Trust

8.04%

BlackRock Institutional Trust Company, N.A.

7.42%

Schwartz (Alice N)

4.29%

Other

61.29%

持股股东

占比

First Eagle Investment Management, L.L.C.

10.36%

The Vanguard Group, Inc.

8.59%

Alice N. Schwartz Revocable Trust

8.04%

BlackRock Institutional Trust Company, N.A.

7.42%

Schwartz (Alice N)

4.29%

Other

61.29%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

42.73%

Investment Advisor

39.24%

Individual Investor

8.14%

Corporation

8.05%

Hedge Fund

5.69%

Research Firm

1.93%

Bank and Trust

1.28%

Pension Fund

1.16%

Sovereign Wealth Fund

0.64%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

1114

24.05M

108.63%

-2.78M

2025Q1

1170

23.54M

106.01%

-2.87M

2024Q4

1159

23.02M

100.37%

-3.90M

2024Q3

1144

23.65M

103.58%

-2.77M

2024Q2

1163

23.92M

102.32%

-878.39K

2024Q1

1175

22.36M

95.71%

-2.57M

2023Q4

1205

22.70M

94.11%

-2.35M

2023Q3

1189

22.91M

95.16%

-1.86M

2023Q2

1192

23.05M

93.93%

-1.30M

2023Q1

1200

23.34M

95.18%

-1.09M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

First Eagle Investment Management, L.L.C.

2.29M

10.36%

+728.07K

+46.49%

Apr 30, 2025

The Vanguard Group, Inc.

1.90M

8.59%

-10.12K

-0.53%

Mar 31, 2025

Alice N. Schwartz Revocable Trust

1.78M

8.04%

-3.19K

-0.18%

Feb 24, 2025

BlackRock Institutional Trust Company, N.A.

1.64M

7.42%

-4.83K

-0.29%

Mar 31, 2025

Schwartz (Alice N)

951.13K

4.3%

+2.20K

+0.23%

Feb 24, 2025

Veritas Asset Management LLP

913.12K

4.12%

-63.70K

-6.52%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

877.04K

3.96%

+130.92K

+17.55%

Mar 31, 2025

Ariel Investments, LLC

724.66K

3.27%

+164.14K

+29.28%

Mar 31, 2025

State Street Global Advisors (US)

694.52K

3.14%

+4.36K

+0.63%

Mar 31, 2025

EARNEST Partners, LLC

599.62K

2.71%

-18.43K

-2.98%

Mar 31, 2025

持股ETF

更新时间: 4 小时前

机构名称

占比

Parnassus Value Select ETF

2.78%

VanEck Morningstar ESG Moat ETF

2.29%

First Trust Indxx Medical Devices ETF

1.89%

Alger Russell Innovation ETF

1.78%

ROBO Global Healthcare Technology & Innovation ETF

1.57%

VanEck Morningstar Wide Moat Growth ETF

1.16%

Schwab Ariel Opportunities ETF

1.14%

Pacer US Export Leaders ETF

1.02%

FPA Global Equity ETF

1.01%

First Eagle Global Equity ETF

0.84%

Parnassus Value Select ETF

占比2.78%

VanEck Morningstar ESG Moat ETF

占比2.29%

First Trust Indxx Medical Devices ETF

占比1.89%

Alger Russell Innovation ETF

占比1.78%

ROBO Global Healthcare Technology & Innovation ETF

占比1.57%

VanEck Morningstar Wide Moat Growth ETF

占比1.16%

Schwab Ariel Opportunities ETF

占比1.14%

Pacer US Export Leaders ETF

占比1.02%

FPA Global Equity ETF

占比1.01%

First Eagle Global Equity ETF

占比0.84%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Bio Rad Laboratories Inc

284.600USD

Bio Rad Laboratories Inc

284.600

概览

公司

财务